Skip to main content
Adam Feuerstein on Muck Rack

Adam Feuerstein

Verified
  • Senior Biotech Writer, STAT
Boston
As seen in: STAT, Business Insider, Forbes, Scribd, CNBC, Fox News, MIT News, PBS NewsHour, Boston.com, Scientific American, Flipboard and
Biotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Adam

Contact Adam, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

931 days. The drug approval scandal hiding in plain sight

|
By Adam Feuerstein Verified
| Flipboard
Metals 3 hours ago World-First 'Super Alloy' Could Transform The Way Metals Are Made ScienceAlert - David Nield • 3h Metal alloys are used everywhere from aircraft to cutlery, making them an indispensable part of modern life.
Open in Who Shared Issue with article?

Halfway into the year, biotech is booming

|
By Adam Feuerstein Verified
| EIN News
Plus: What to expect at the FDA’s Capricor advisory panel meeting Mark Lennihan/AP By Adam Feuerstein July 2, 2026 Senior Writer, Biotech Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54.
Open in Who Shared Issue with article?

‘Synthetic lethality’ could trigger another round of biotech M&A

|
By Adam Feuerstein Verified
| EIN News
Enthusiasm about the approach to cancer treatment could trigger some creative deal-making This image shows pancreatic cancer cells (nuclei in blue) growing as a sphere encased in membranes.National Cancer Institute/USC Norris Comprehensive Cancer Center By Adam Feuerstein June 11, 2026 Senior Writer, Biotech Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology.
Open in Who Shared Issue with article?
See all 1,410 licensed articles (3,417 Total)